Novel Liposomal Formulation of Baicalein for the Treatment of Pancreatic Ductal Adenocarcinoma: Design, Characterization, and Evaluation

Pancreatic cancer (PC) is one of the deadliest cancers so there is an urgent need to develop new drugs and therapies to treat it. Liposome-based formulations of naturally-derived bioactive compounds are promising anticancer candidates due to their potential for passive accumulation in tumor tissues, protection against payload degradation, and prevention of non-specific toxicity. We chose the naturally-derived flavonoid baicalein (BAI) due to its promising effect against pancreatic ductal adenocarcinoma (PDAC) and encapsulated it into a liposomal bilayer using the passive loading method, with an almost 90% efficiency. We performed a morphological and stability analysis of the obtained BAI liposomal formulation and evaluated its activity on two-dimensional and three-dimensional pancreatic cell models. As the result, we obtained a stable BAI-encapsulated liposomal suspension with a size of 100.9 nm ± 2.7 and homogeneity PDI = 0.124 ± 0.02, suitable for intravenous administration. Furthermore, this formulation showed high cytotoxic activity towards AsPC-1 and BxPC-3 PDAC cell lines (IC50 values ranging from 21 ± 3.6 µM to 27.6 ± 4.1 µM), with limited toxicity towards normal NHDF cells and a lack of hemolytic activity. Based on these results, this new BAI liposomal formulation is an excellent candidate for potential anti-PDAC therapy.

[1]  Eithne Costello,et al.  Recent advances in understanding pancreatic cancer , 2022, Faculty reviews.

[2]  Peng Liu,et al.  A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives , 2022, Molecules.

[3]  S. Vicent,et al.  PDAC as an Immune Evasive Disease: Can 3D Model Systems Aid to Tackle This Clinical Problem? , 2021, Frontiers in Cell and Developmental Biology.

[4]  J. Sharifi‐Rad,et al.  Quercetin Impact in Pancreatic Cancer: An Overview on Its Therapeutic Effects , 2021, Oxidative medicine and cellular longevity.

[5]  Esteban Rodríguez-Arce,et al.  Antioxidant properties of flavonoid metal complexes and their potential inclusion in the development of novel strategies for the treatment against neurodegenerative diseases. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[6]  C. Pilarsky,et al.  Pre-clinical Models of Metastasis in Pancreatic Cancer , 2021, Frontiers in Cell and Developmental Biology.

[7]  F. Gao,et al.  Pancreatic cancer: A review of epidemiology, trend, and risk factors , 2021, World journal of gastroenterology.

[8]  M. Korc,et al.  The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy , 2021, Frontiers in Oncology.

[9]  I. Chau,et al.  Targeting the Stroma in the Management of Pancreatic Cancer , 2021, Frontiers in Oncology.

[10]  M. Kumar,et al.  The Therapeutic Potential of Wogonin Observed in Preclinical Studies , 2021, Evidence-based complementary and alternative medicine : eCAM.

[11]  M. Nowicki,et al.  Drug resistance evaluation in novel 3D in vitro model. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[12]  Martin Engel,et al.  Generation and Analysis of 3D Cell Culture Models for Drug Discovery. , 2021, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[13]  H. Mao,et al.  Mitochondrion-specific dendritic lipopeptide liposomes for targeted sub-cellular delivery , 2021, Nature Communications.

[14]  Lianyu Chen,et al.  Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling , 2021, BMC Cancer.

[15]  J. Gubernator,et al.  The Comparison of In Vitro Photosensitizing Efficacy of Curcumin-Loaded Liposomes Following Photodynamic Therapy on Melanoma MUG-Mel2, Squamous Cell Carcinoma SCC-25, and Normal Keratinocyte HaCaT Cells , 2021, Pharmaceuticals.

[16]  B. Baradaran,et al.  Pancreatic Cancer Signaling Pathways, Genetic Alterations, and Tumor Microenvironment: The Barriers Affecting the Method of Treatment , 2021, Biomedicines.

[17]  A. Naiki‐Ito,et al.  DPYD, down-regulated by the potentially chemopreventive agent luteolin, interacts with STAT3 in pancreatic cancer , 2021, Carcinogenesis.

[18]  Jin-yu Yang,et al.  Pharmacological properties of baicalin on liver diseases: a narrative review , 2021, Pharmacological Reports.

[19]  S. Iurciuc,et al.  Plant-Derived Anticancer Compounds as New Perspectives in Drug Discovery and Alternative Therapy , 2021, Molecules.

[20]  S. A. Rizvi,et al.  Characterization and Applications of Colloidal Systems as Versatile Drug Delivery Carriers for Parenteral Formulations , 2021, Pharmaceuticals.

[21]  S. Mackinnon,et al.  Liposomes embedded within fibrin gels facilitate localized macrophage manipulations within nerve , 2020, Journal of Neuroscience Methods.

[22]  M. Ashrafizadeh,et al.  Apigenin as Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer , 2020, Frontiers in Chemistry.

[23]  R. Andersson,et al.  The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data , 2020, Scientific Reports.

[24]  T. Minko,et al.  Development of Liposomal Vesicles for Osimertinib Delivery to EGFR Mutation—Positive Lung Cancer Cells , 2020, Pharmaceutics.

[25]  J. Irache,et al.  Berberine-Loaded Liposomes for the Treatment of Leishmania infantum-Infected BALB/c Mice , 2020, Pharmaceutics.

[26]  K. Miłowska,et al.  Spheroids as a Type of Three-Dimensional Cell Cultures—Examples of Methods of Preparation and the Most Important Application , 2020, International journal of molecular sciences.

[27]  D. Haro,et al.  Metabolic Impact of Flavonoids Consumption in Obesity: From Central to Peripheral , 2020, Nutrients.

[28]  A. Minelli,et al.  Prognostic and predictive factors in pancreatic cancer , 2020, Oncotarget.

[29]  Mi-Kyung Lee.  Liposomes for Enhanced Bioavailability of Water-Insoluble Drugs: In Vivo Evidence and Recent Approaches , 2020, Pharmaceutics.

[30]  Ankang Li,et al.  Quercetin liposomes ameliorate streptozotocin-induced diabetic nephropathy in diabetic rats , 2020, Scientific Reports.

[31]  J. Bernatonienė,et al.  Flavonoids as Anticancer Agents , 2020, Nutrients.

[32]  Bradley W. Bolling,et al.  Flavonoids and gut health. , 2020, Current opinion in biotechnology.

[33]  Huihui Fan,et al.  Solubility and thermodynamic properties of baicalein in water and ethanol mixtures from 283.15 to 328.15 K , 2019 .

[34]  Z. Selamoğlu,et al.  Liposomal Cytarabine as Cancer Therapy: From Chemistry to Medicine , 2019, Biomolecules.

[35]  F. Greco,et al.  Metal complexes of flavonoids: their synthesis, characterization and enhanced antioxidant and anticancer activities. , 2019, Future medicinal chemistry.

[36]  Jun Yang,et al.  Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: an overview. , 2019, International journal of pharmaceutics.

[37]  Huan Meng,et al.  Transcytosis - An effective targeting strategy that is complementary to “EPR effect” for pancreatic cancer nano drug delivery , 2019, Theranostics.

[38]  T. Niidome,et al.  Glycol Chitosan-Docosahexaenoic Acid Liposomes for Drug Delivery: Synergistic Effect of Doxorubicin-Rapamycin in Drug-Resistant Breast Cancer , 2019, Marine drugs.

[39]  P. Choyke,et al.  Enhanced nanodrug delivery in tumors after near-infrared photoimmunotherapy , 2019, Nanophotonics.

[40]  C. Pilarsky,et al.  Chemoresistance in Pancreatic Cancer , 2019, International journal of molecular sciences.

[41]  C. Belka,et al.  Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches , 2019, Radiation oncology.

[42]  M. Moreau,et al.  Flavonoid Derivative of Cannabis Demonstrates Therapeutic Potential in Preclinical Models of Metastatic Pancreatic Cancer , 2019, Front. Oncol..

[43]  A. Di Sotto,et al.  SPC Liposomes as Possible Delivery Systems for Improving Bioavailability of the Natural Sesquiterpene β-Caryophyllene: Lamellarity and Drug-Loading as Key Features for a Rational Drug Delivery Design , 2018, Pharmaceutics.

[44]  Bing Zhang,et al.  A strategy to improve the oral availability of baicalein: The baicalein-theophylline cocrystal. , 2018, Fitoterapia.

[45]  R. Ho,et al.  Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII , 2018, International journal of nanomedicine.

[46]  Chien-Liang Fang,et al.  Liposome-Encapsulated Baicalein Suppressed Lipogenesis and Extracellular Matrix Formation in Hs68 Human Dermal Fibroblasts , 2018, Front. Pharmacol..

[47]  C. Simone,et al.  Liposomes: Clinical Applications and Potential for Image-Guided Drug Delivery , 2018, Molecules.

[48]  X. Wen,et al.  Liposome-delivered baicalein induction of myeloid leukemia K562 cell death via reactive oxygen species generation , 2018, Molecular medicine reports.

[49]  Arash Rafii,et al.  Halfway between 2D and Animal Models: Are 3D Cultures the Ideal Tool to Study Cancer-Microenvironment Interactions? , 2018, International journal of molecular sciences.

[50]  Bingqing Zhu,et al.  Cocrystals of Baicalein with Higher Solubility and Enhanced Bioavailability , 2017 .

[51]  Jian Yang,et al.  Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides , 2017, International journal of nanomedicine.

[52]  Ji Hee Kang,et al.  The Effect of Surface Charges on the Cellular Uptake of Liposomes Investigated by Live Cell Imaging , 2017, Pharmaceutical Research.

[53]  Sheela Chandra,et al.  Flavonoids: an overview , 2016, Journal of Nutritional Science.

[54]  Hui Liu,et al.  International Journal of Molecular Sciences the Fascinating Effects of Baicalein on Cancer: a Review , 2022 .

[55]  J. Fernandez-Checa,et al.  Mitochondria, cholesterol and cancer cell metabolism , 2016, Clinical and Translational Medicine.

[56]  H. Podbielska,et al.  The cellular internalization of liposome encapsulated protoporphyrin IX by HeLa cells. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[57]  N. Stone,et al.  Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions , 2016, Drugs.

[58]  Alessandro Bevilacqua,et al.  3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained , 2016, Scientific Reports.

[59]  J. Ochocki,et al.  Properties and applications of flavonoid metal complexes , 2015 .

[60]  Ju Liang,et al.  Long-circulating nanoliposomes (LCNs) sustained delivery of baicalein (BAI) with desired oral bioavailability in vivo , 2013, Drug delivery.

[61]  S. Barnert,et al.  Vitamin C-driven epirubicin loading into liposomes , 2013, International journal of nanomedicine.

[62]  T. Waite,et al.  Fenton-like copper redox chemistry revisited: Hydrogen peroxide and superoxide mediation of copper-catalyzed oxidant production , 2013 .

[63]  G. Eibl,et al.  Baicalein--an intriguing therapeutic phytochemical in pancreatic cancer. , 2012, Current drug targets.

[64]  Jaroslav Turánek,et al.  Liposomal paclitaxel formulations. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[65]  H. Kasukawa,et al.  Comparative studies of polyethylene glycol-modified liposomes prepared using different PEG-modification methods. , 2012, Biochimica et biophysica acta.

[66]  Ye Fang,et al.  Liposomal quercetin: evaluating drug delivery in vitro and biodistribution in vivo , 2012, Expert opinion on drug delivery.

[67]  G. De Rosa,et al.  Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: a potential theranostic agent , 2012, International journal of nanomedicine.

[68]  A. Kozubek,et al.  Membrane perturbations induced by new analogs of neocryptolepine. , 2012, Biological & pharmaceutical bulletin.

[69]  Ethan Y. Brovman,et al.  Baicalein, a component of Scutellaria baicalensis, induces apoptosis by Mcl-1 down-regulation in human pancreatic cancer cells. , 2011, Biochimica et biophysica acta.

[70]  Jun Fang,et al.  The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. , 2011, Advanced drug delivery reviews.

[71]  Q. Dou,et al.  Turning tumor-promoting copper into an anti-cancer weapon via high-throughput chemistry. , 2010, Current medicinal chemistry.

[72]  U. Majewska,et al.  Selenium, copper, and zinc concentrations in intestinal cancer tissue and in colon and rectum polyps , 2003, Biological Trace Element Research.

[73]  P. Rose,et al.  Pegylated liposomal doxorubicin in ovarian cancer , 2006, International journal of nanomedicine.

[74]  P. Olive,et al.  Drug and radiation resistance in spheroids: cell contact and kinetics , 1994, Cancer and Metastasis Reviews.

[75]  立道 昌幸.  International Agency of Research on Cancer 国際癌研究機構(IARC)留学記 , 2003 .

[76]  Y. Sakihama,et al.  Plant phenolic antioxidant and prooxidant activities: phenolics-induced oxidative damage mediated by metals in plants. , 2002, Toxicology.

[77]  D. Tzemach,et al.  Dose Dependency of Pharmacokinetics and Therapeutic Efficacy of Pegylated Liposomal Doxorubicin (DOXIL) in Murine Models , 2002, Journal of drug targeting.

[78]  S. Goldstein,et al.  The Fenton reagents. , 1993, Free radical biology & medicine.

[79]  A. Piccoli,et al.  Copper, zinc and copper/zinc ratio in chronic pancreatitis and pancreatic cancer. , 1985, Clinical biochemistry.

[80]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[81]  J C Stewart,et al.  Colorimetric determination of phospholipids with ammonium ferrothiocyanate. , 1980, Analytical biochemistry.